Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Hedlund, Ludwig
DOB:	02-MAR-1950 (Age: 75)
Gender:	male
Address:	Djursbo 24 820 64 Näsviken (Sweden)
ID:	1380-437420-8

Report
Date:	12-NOV-2024

Laboratory
dr Ample, Ex Boulevard du Jardin Botanique 32 1000 Brussels

Requested by
Hudiksvalls sjukhus Kungsgatan 33 824 30 Hudiksvall (Sweden)

Specimen
Collected:	11-NOV-2024

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test	11 Nov 2024	Reference Range	Unit
Glucose [Mass/volume] in Blood	95.5	70 - 140	mg/dL
Urea nitrogen [Mass/volume] in Blood	9.2	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	2.9 H	0.9 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	9.8	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	139.8	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.9	3.5 - 5.3	mmol/L
Chloride [Moles/volume] in Blood	109.7 H	98 - 108	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	26.7	24 - 29	mmol/L
Protein [Mass/volume] in Serum or Plasma	7.7	6.6 - 8.3	g/dL
Albumin [Mass/volume] in Serum or Plasma	4.6	3.5 - 5.5	g/dL
Globulin [Mass/volume] in Serum by calculation	2.5	1.5 - 3.5	g/L
Bilirubin.total [Mass/volume] in Serum or Plasma	0.4	0.2 - 1.2	mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma	76.3	39 - 150	U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma	24.5	10 - 60	U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma	16.6	10 - 40	U/L
Cholesterol [Mass/volume] in Serum or Plasma	162.0	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	192.9 H	65 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	95.3	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	72.0	40 - 100	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows persistently elevated creatinine, indicating chronic kidney dysfunction. Triglycerides remain high, though lipid profile has improved over time. Mild hyperchloremia is noted. Previous anemia and thrombocytopenia were present. Liver function is currently stable, and glucose control is adequate. Markedly elevated bilirubin and troponin I in 2022 suggest prior acute events, but these have normalized. Overall, main concerns are chronic kidney disease and dyslipidemia; continued monitoring and management are recommended.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows persistently elevated creatinine, indicating chronic kidney dysfunction. Triglycerides remain high, though lipid profile has improved over time. Mild hyperchloremia is noted. Previous anemia and thrombocytopenia were present. Liver function is currently stable, and glucose control is adequate. Markedly elevated bilirubin and troponin I in 2022 suggest prior acute events, but these have normalized. Overall, main concerns are chronic kidney disease and dyslipidemia; continued monitoring and management are recommended.